KORNITZER CAPITAL MANAGEMENT INC /KS
Position in NUVB — Nuvation Bio Inc.
CIK 898358
SHAWNEE MISSION, KS
Position in NUVB
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$634,383
New position
Shares Held
147,875
first reported quarter
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026KORNITZER CAPITAL MANAGEMENT INC /KS holds $45,330,914 across 13 Biotechnology names. NUVB ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
60,342 | $12,047,280 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
113,499 | $7,335,440 | |
| 3 | TECH |
BIO-TECHNE Corp
|
130,270 | $6,807,910 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
175,870 | $4,143,497 | |
| 5 | VCEL |
Vericel Corp
|
113,944 | $3,665,578 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
35,780 | $2,243,406 | |
| 7 | ZYME |
Zymeworks Inc.
|
88,800 | $2,223,552 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
29,105 | $2,185,494 |
All Filings in NUVB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $634,383 | 147,875 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||